Norges Bank’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-181,886
| Closed | -$102M | – | 831 |
|
|
2025
Q4 | $102M | Buy |
+181,886
| New | +$103M | 0.01% | 752 |
|
|
2025
Q3 | – | Sell |
-212,188
| Closed | -$66.6M | – | 928 |
|
|
2025
Q2 | $66.6M | Sell |
212,188
-26,379
| -11% | -$7.92M | 0.01% | 839 |
|
|
2025
Q1 | $72.7M | Buy |
238,567
+28,295
| +13% | +$9.52M | 0.01% | 805 |
|
|
2024
Q4 | $69.9M | Sell |
210,272
-25,229
| -11% | -$8.56M | 0.01% | 830 |
|
|
2024
Q3 | $78.6M | Sell |
235,501
-44,084
| -16% | -$16.7M | 0.01% | 775 |
|
|
2024
Q2 | $115M | Buy |
279,585
+28,560
| +11% | +$11.3M | 0.02% | 593 |
|
|
2024
Q1 | $101M | Buy |
251,025
+58,016
| +30% | +$20.4M | 0.02% | 641 |
|
|
2023
Q4 | $59.2M | Buy |
193,009
+25,989
| +16% | +$7.02M | 0.01% | 831 |
|
|
2023
Q3 | $40.4M | Buy |
167,020
+16,700
| +11% | +$4.27M | 0.01% | 935 |
|
|
2023
Q2 | $36.1M | Sell |
150,320
-74,013
| -33% | -$15.4M | 0.01% | 1013 |
|
|
2023
Q1 | $42.2M | Buy |
224,333
+17,293
| +8% | +$3.58M | 0.01% | 916 |
|
|
2022
Q4 | $44M | Buy |
207,040
+57,283
| +38% | +$11.4M | 0.01% | 858 |
|
|
2022
Q3 | $23.5M | Sell |
149,757
-98,080
| -40% | -$15.7M | 0.01% | 1128 |
|
|
2022
Q2 | $37.1M | Buy |
247,837
+48,305
| +24% | +$6.99M | 0.01% | 914 |
|
|
2022
Q1 | $32.6M | Sell |
199,532
-63,946
| -24% | -$10.5M | 0.01% | 1118 |
|
|
2021
Q4 | $57.3M | Buy |
263,478
+4,943
| +2% | +$1.04M | 0.01% | 872 |
|
|
2021
Q3 | $48.9M | Sell |
258,535
-12,967
| -5% | -$2.37M | 0.01% | 936 |
|
|
2021
Q2 | $48M | Sell |
271,502
-12,818
| -5% | -$2.21M | 0.01% | 993 |
|
|
2021
Q1 | $46.6M | Sell |
284,320
-49,300
| -15% | -$7.54M | 0.01% | 1012 |
|
|
2020
Q4 | $46.4M | Sell |
333,620
-51,239
| -13% | -$6.46M | 0.01% | 1027 |
|
|
2020
Q3 | $43M | Sell |
384,859
-27,346
| -7% | -$3.16M | 0.01% | 916 |
|
|
2020
Q2 | $38.3M | Buy |
412,205
+14,980
| +4% | +$1.27M | 0.01% | 1019 |
|
|
2020
Q1 | $29.1M | Hold |
397,225
| – | – | 0.01% | 998 |
|
|
2019
Q4 | $33.4M | Hold |
397,225
| – | – | 0.01% | 1183 |
|
|
2019
Q3 | $33.4M | Hold |
397,225
| – | – | 0.01% | 1136 |
|
|
2019
Q2 | $26M | Buy |
397,225
+53,761
| +16% | +$3.1M | 0.01% | 1335 |
|
|
2019
Q1 | $20.3M | Buy |
343,464
+192,239
| +127% | +$11.5M | 0.01% | 1497 |
|
|
2018
Q4 | $8M | Hold |
151,225
| – | – | ﹤0.01% | 1814 |
|
|
2018
Q3 | $9.06M | Buy |
151,225
+48,008
| +47% | +$2.63M | ﹤0.01% | 1842 |
|
|
2018
Q2 | $4.44M | Buy |
103,217
+66,213
| +179% | +$2.67M | ﹤0.01% | 1968 |
|
|
2018
Q1 | $1.29M | Hold |
37,004
| – | – | ﹤0.01% | 2041 |
|
|
2017
Q4 | $1.34M | Sell |
37,004
-46,327
| -56% | -$1.62M | ﹤0.01% | 2025 |
|
|
2017
Q3 | $2.66M | Buy |
+83,331
| New | +$2.55M | ﹤0.01% | 1946 |
|
Other funds holding MEDP
VPM
VCM
WA
Norges Bank's MEDP Position: Q1 2026 in Review
Norges Bank sold out of Medpace (MEDP) in Q1 2026, closing a stake of 181,886 shares — an estimated $102M sold.
Norges Bank first reported a position in MEDP in Q3 2017 and held it in 33 quarters. The position peaked at $115M in Q2 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Norges Bank reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
- Norges Bank sold 181,886 Medpace shares in Q1 2026, an estimated $102M.
- Norges Bank first reported a position in Medpace in Q3 2017 and held it in 33 quarters.
- Norges Bank's Medpace position peaked at $115M in Q2 2024.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Norges Bank's 13F filing for Q1 2026.